WebsiteGear Logo Log In
New User? Sign Up
About | Contact | FAQ
  Home News Web Hosting Web Host Industry Monday, January 17, 2022 
Add Press Release News | News Feeds Feeds | Email This News Email


Using Digital Pathology to Determine the Role of Tumor-Infiltrating B-Cells in Clinical Outcomes of Patients with Melanoma, Upcoming Webinar Hosted by Xtalks
Tuesday, December 7, 2021

In this free webinar, the featured speaker will discuss how biomarker analysis with digital pathology coupled with analysis of gene expression can identify T- and B-cell signatures with prognostic value in melanoma. Attendees will learn how digital image analysis can identify tumor and stroma compartments and perform cell-by-cell analysis of biomarker positivity within the respective compartments to identify and quantify cellular phenotypes and provide insight into interactions between T- and B-cells.

TORONTO, Nov. 29, 2021 /PRNewswire-PRWeb/ -- Biomarkers are needed to identify patients who benefit most from targeted or immune checkpoint inhibitor (ICI) therapy in metastatic melanoma. This webinar will share an analysis of biomarkers using pre-treatment melanoma samples from the dabrafenib plus trametinib arm of the randomized, Phase III COMBI-v trial using the HALO® image analysis platform combined with gene expression analysis using the Nanostring nCounter technology.

This is believed to be the first large-scale analysis of gene expression signatures, tumor cell interactions and T- and B-cell interactions by digital pathology in patients treated with targeted therapy. Distinct T-cell/B-cell signatures at baseline demonstrated prognostic value, as high T-cell/low B-cell signatures were associated with prolonged survival vs. high T-cell/high B-cell signatures. B cells may be potential biomarkers to identify patients who could achieve improved clinical benefit.

Join this webinar to learn:

    --  How biomarker analysis with digital pathology coupled with gene
        expression analysis can identify T- and B-cell signatures with
        prognostic value in melanoma
    --  How digital image analysis can identify tumor and stroma compartments
        and perform cell-by-cell analysis of biomarker positivity within the
        respective compartments to identify and quantify cellular phenotypes
    --  How spatial analysis can provide insight into interactions between T-
        and B-cells

Join Ken Schultz, Principal Scientist, Novartis, for the live webinar on Wednesday, December 15, 2021 at 1pm EST.

For more information, or to register for this event, visit Using Digital Pathology to Determine the Role of Tumor-Infiltrating B-Cells in Clinical Outcomes of Patients with Melanoma.

ABOUT INDICA LABS

Indica Labs software solutions provide fast, quantitative evaluation of whole slide tissues using HALO® and HALO AI(TM) for image analysis and HALO Link(TM) and HALO AP® to manage images, data, and facilitate collaboration. With unmatched ease-of-use and scalability, pharmaceutical, healthcare, and research organizations worldwide are using HALO for high-throughput, whole-slide image quantification in areas such as oncology, immuno-oncology, neuroscience, ophthalmology, metabolism, and toxicological pathology.

To learn more about Indica Labs, visit https://indicalab.com/

Contact:
info@indicalab.com

ABOUT XTALKS

Xtalks, powered by Honeycomb Worldwide Inc., is a leading provider of educational webinars to the global life science, food and medical device community. Every year, thousands of industry practitioners (from life science, food and medical device companies, private & academic research institutions, healthcare centers, etc.) turn to Xtalks for access to quality content. Xtalks helps Life Science professionals stay current with industry developments, trends and regulations. Xtalks webinars also provide perspectives on key issues from top industry thought leaders and service providers.

To learn more about Xtalks visit http://xtalks.com
For information about hosting a webinar visit http://xtalks.com/why-host-a-webinar/

Media Contact

Ayesha Rashid, Xtalks, +1 (416) 977-6555 x 272, arashid@xtalks.com

SOURCE Xtalks



Email This News Email | Submit To Slashdot Slashdot | Submit To Digg.com Digg | Submit To del.icio.us Del.icio.us | News Feeds Feeds

RELATED NEWS ARTICLES
Nav Media Professionals Muhammad Al-Yahyai and Dahem Al-Qahtani on "Alaraby: TV" | Jan 17, 2022
Nav Medical Education Market to Grow by USD 143.30 billion | Harvard University and Johns Hopkins University Among Key Market Contributors | Technavio | Jan 17, 2022
Nav Notice of Data Security Incident | Jan 14, 2022
Nav Ribbon Communications to Present at Needham Growth Conference | Jan 14, 2022
Nav M&S Technologies introduces the CTS Distance One(TM) ultrasonic distance measurement device for use in ophthalmic Clinical Trials | Jan 14, 2022
Nav TCN to Host First Annual C3 Virtual User Group Conference for Contact Center Professionals | Jan 14, 2022
Nav WindRose Health Investors Completes the Sale of basys to BPOC and Five Arrows Capital | Jan 14, 2022
Nav CONVERGEONE ACQUIRES INTEGRATION PARTNERS CORPORATION, EXPANDING PRESENCE IN NEW ENGLAND AND MIDWEST | Jan 14, 2022
Nav Northeastern Regional Information Center (NY) to Offer Synergy Education Platform to Member Districts | Jan 14, 2022
Nav Intl. talent hub, legal service district launched in Qianhai | Jan 14, 2022
NEWS SEARCH

FEATURED NEWS | POPULAR NEWS
Submit News | View More News View More News